Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07237438 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TIVA Versus Balanced Anesthesia on Muscle Mass in CRC Surgery

Study acronym: TIVABAL-CRC
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Primary completion date changed from estimate of Feb 2026 to Feb 20, 2026
    • Study completion date changed from estimate of Jun 2026 to Jun 20, 2026
    • Start date: Sep 20, 2025 to Sep 27, 2025
    • Site details revised
    • Eligibility criteria expanded, about 5 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is aimed at clarifying changes in body composition during the perioperative period and identifying risk factors for skeletal muscle mass loss in patients with colorectal cancer. The investigators will asess the impact of the type of anaesthesia (total intravenous anaesthesia/sevoflurane anaesthesia) for colorectal surgery on the muscle function and mass, which will be evaluated using ultrasound, dynamometry and bioimpedance.
Trial Details
NCT Number NCT07237438
Lead Sponsor Grigore T. Popa University of Medicine and Pharmacy
Collaborators: Regional Institute of Oncology, Iasi, Romania
Conditions
(from sponsor)		 Colorectal Cancer (CRC), Sarcopenia
Related terms Colorectal Neoplasms, Sarcopenia
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov